Fortis’ S.L. Raheja Hospital’s First Bone Marrow Transplant
Mumbai, Maharashtra, October 20, 2025: In a landmark medical achievement, S.L. Raheja Hospital, Mahim – A Fortis Associate, has successfully completed its first Bone Marrow Transplant (BMT) at the Centre of Excellence for Haemato-Oncology, marking a major step forward in advanced cancer care in India.
The procedure was performed on 61-year-old Bijayentimala Devi from Manipur, diagnosed with Multiple Myeloma, a complex form of blood cancer. The patient underwent an autologous stem cell transplant, a procedure using her own stem cells to rebuild healthy bone marrow. Following the transplant, she showed remarkable recovery — gaining strength, weight, and overall vitality.
Expert Team Behind the Breakthrough
The successful transplant was led by the hospital’s experienced team of Haemato-Oncologists and Bone Marrow Transplant specialists, including Dr. Abhay Bhave (Senior Consultant), Dr. Shreya Agrawal (Consultant), and Dr. Shrinath Kshirsagar (Consultant).
They were supported by a multidisciplinary team of clinicians and nurses, backed by state-of-the-art facilities equipped with advanced infection-control systems, precision monitoring tools, and specialized post-transplant recovery units.
Commenting on the milestone, Dr. Kunal Punamiya, CEO of S.L. Raheja Hospital, said:
“This marks a defining moment in our hospital’s journey toward clinical excellence. It demonstrates our commitment to delivering life-saving treatments with compassion and innovation. Our success reflects how teamwork and technology together can transform patient care.”
A Story of Hope and Healing
For the patient’s family, the journey was deeply emotional. Mr. Khamba, the patient’s husband, expressed heartfelt gratitude:
“From the moment we arrived, the care and attention given by the doctors and staff were exceptional. They treated us like family. Seeing my wife recover and smile again is nothing short of a miracle. We will always be thankful to the team at S.L. Raheja Hospital for giving her a new lease on life.”
Now fully recovered, the patient has been discharged — just in time to celebrate Diwali, symbolizing the triumph of light, health, and hope over illness and adversity.
Redefining Cancer Care in India
This achievement highlights S.L. Raheja Hospital’s growing expertise in bone marrow transplants, offering patients access to world-class treatments for conditions such as leukemia, lymphoma, and multiple myeloma. The hospital’s COE for Haemato-Oncology is designed to provide integrated, patient-centric care through cutting-edge technology, personalized treatment plans, and holistic rehabilitation support.
For patients across India, especially those from remote regions like Manipur, this milestone reinforces Fortis’ mission to make advanced healthcare accessible and affordable.
According to the clinical team, a Bone Marrow Transplant is often the only curative option for many blood cancers and disorders. The success of this case serves as a beacon of hope for patients battling similar conditions across the country.
About Fortis Healthcare
Fortis Healthcare Limited is one of India’s leading integrated healthcare service providers, operating 33 hospitals across 11 states, with more than 5,700 operational beds and 400 diagnostic centers. The company continues to expand its medical footprint across oncology, neurology, cardiology, and transplant medicine, driving innovation and excellence in every aspect of patient care.
A New Dawn for Patients
The first successful Bone Marrow Transplant at S.L. Raheja Hospital stands as a testament to medical innovation, teamwork, and compassion. It marks not only clinical success but also a celebration of resilience and renewed life for patients battling cancer.
With this milestone, the hospital reaffirms its commitment to offering hope, healing, and high-quality care — setting a new benchmark for advanced oncology treatment in India.